Section menu


  1. de Boer, S. M., B. G. Wortman, T. Bosse, M. E. Powell, N. Singh, H. Hollema, G. Wilson, M. N. Chowdhury, L. Mileshkin, J. Pyman, D. Katsaros, S. Carinelli, A. Fyles, C. M. McLachlin, C. Haie-Meder, P. Duvillard, R. A. Nout, K. W. Verhoeven-Adema, H. Putter, C. L. Creutzberg, and Vthbm Smit. 2018. 'Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer', Ann Oncol, 29: 424-30.
  2. Friedlander, M., V. Gebski, E. Gibbs, L. Davies, R. Bloomfield, F. Hilpert, L. B. Wenzel, D. Eek, M. Rodrigues, A. Clamp, R. T. Penson, D. Provencher, J. Korach, T. Huzarski, L. Vidal, V. Salutari, C. Scott, M. O. Nicoletto, K. Tamura, D. Espinoza, F. Joly, and E. Pujade-Lauraine. 2018. 'Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial', Lancet Oncol, 19: 1126-34.
  3. Garsed, D. W., K. Alsop, S. Fereday, C. Emmanuel, C. J. Kennedy, D. Etemadmoghadam, B. Gao, V. Gebski, V. Gares, E. L. Christie, M. C. A. Wouters, K. Milne, J. George, A. M. Patch, J. Li, G. M. Arnau, T. Semple, S. R. Gadipally, Y. E. Chiew, J. Hendley, T. Mikeska, G. V. Zapparoli, K. Amarasinghe, S. M. Grimmond, J. V. Pearson, N. Waddell, J. Hung, C. J. R. Stewart, R. Sharma, P. E. Allan, P. F. Rambau, O. McNally, L. Mileshkin, A. Hamilton, S. Ananda, M. Grossi, P. A. Cohen, Y. C. Leung, R. M. Rome, P. Beale, P. Blomfield, M. Friedlander, A. Brand, A. Dobrovic, M. Kobel, P. Harnett, B. H. Nelson, D. D. L. Bowtell, and A. deFazio. 2018. 'Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer', Clin Cancer Res, 24: 569-80.
  4. Goergen, S. K., E. Posma, D. Wrede, J. Collett, J. Pyman, E. Alibrahim, J. Keene, and A. Dobrotwir. 2018. 'Interobserver agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders', Clin Radiol, 73: 908 e1-08 e9.
  5. Hamilton, C. A., A. Miller, Y. Casablanca, N. S. Horowitz, B. Rungruang, T. C. Krivak, S. D. Richard, N. Rodriguez, M. J. Birrer, F. J. Backes, M. A. Geller, M. Quinn, M. J. Goodheart, D. G. Mutch, J. J. Kavanagh, G. L. Maxwell, and M. A. Bookman. 2018. 'Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study', Gynecol Oncol, 148: 275-80.
  6. Holland, C., A. Hocking, L. Joubert, F. McDermott, M. D. Niski, F. Thomson Salo, and M. A. Quinn. 2018. 'My Kite Will Fly: Improving Communication and Understanding in Young Children When a Mother Is Diagnosed with Life-Threatening Gynecological Cancer', J Palliat Med, 21: 78-84.
  7. Kampan, N. C., S. D. Xiang, O. M. McNally, A. N. Stephens, M. A. Quinn, and M. Plebanski. 2018. 'Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities', Curr Med Chem, 25: 4785-806.
  8. Kondrashova, O., M. Topp, K. Nesic, E. Lieschke, G. Y. Ho, M. I. Harrell, G. V. Zapparoli, A. Hadley, R. Holian, E. Boehm, V. Heong, E. Sanij, R. B. Pearson, J. J. Krais, N. Johnson, O. McNally, S. Ananda, K. Alsop, K. J. Hutt, S. H. Kaufmann, K. K. Lin, T. C. Harding, N. Traficante, A. deFazio, I. A. McNeish, D. D. Bowtell, E. M. Swisher, A. Dobrovic, M. J. Wakefield, and C. L. Scott. 2018. 'Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma', Nat Commun, 9: 3970.
  9. Lee, B., B. Tran, A. L. Hsu, G. R. Taylor, S. B. Fox, A. Fellowes, R. Marquis, J. Mooi, J. Desai, K. Doig, P. Ekert, C. Gaff, D. Herath, A. Hamilton, P. James, A. Roberts, R. Snyder, P. Waring, and G. McArthur. 2018. 'Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting', Intern Med J, 48: 786-94.
  10. Lin, M. Y., A. Dobrotwir, O. McNally, N. R. Abu-Rustum, and K. Narayan. 2018. 'Role of imaging in the routine management of endometrial cancer', Int J Gynaecol Obstet, 143 Suppl 2: 109-17.
  11. Saville, M., and O. McNally. 2018. ''Lest we forget' as we move forward with cervical screening', Aust N Z J Obstet Gynaecol, 58: 265-66

Share this page